Comparison of Side Effects With IFN- in HHT-IFN–Treated Patients and Historical Controls
| Parameter . | Percent of Patients . | P Value . | |
|---|---|---|---|
| HHT/IFN-α (n = 82) . | IFN-α Historical Controls (n = 274) . | ||
| Myalgia/aches | 18 | 36 | <.001 |
| GI disturbances | 20 | 37 | .002 |
| Neurotoxicity | 27 | 27 | NS |
| Fatigue | 43 | 43 | NS |
| Parameter . | Percent of Patients . | P Value . | |
|---|---|---|---|
| HHT/IFN-α (n = 82) . | IFN-α Historical Controls (n = 274) . | ||
| Myalgia/aches | 18 | 36 | <.001 |
| GI disturbances | 20 | 37 | .002 |
| Neurotoxicity | 27 | 27 | NS |
| Fatigue | 43 | 43 | NS |
Abbreviation: NS, not significant.